Autorisation d’accès précoce refusée à la spécialité DUPIXENT (dupilumab).
See also
Décision d'accès précoce
14/11/2024
eNrlWF1v2jAUfe+vQHk3SaC0dApUG2s3pFZjtGjTXirjXMDM2Kk/KN2vn5PQlU6J1pr6pXtBwR/3XtvnnHvt5HSzYo01SEUF7wVxMwoawIlIKZ/3gsn1OeoGp/2DZInX+HFYy45rxnHQIAwr1Qvy3uYUMFfN75cXH8HOBxn0DxqJmC6B6CfjjKas+RmrxSXO8jGNZC1o2liBXoi0F2RGF62NRGlpo+jfCflTZZhAEm5bdnuXN4e77UmYG3uGVaNAXmA+rzQK3MkmMVIC1wOsYS7kfU28bSfbVI1BCSMJjLBejKRY0xTSShczzBQ4OZndpVcg1wx07qTSeLgkK+VkHC/xZgy3w+qg39vegd5oFKH4uNvuxlG72z1qHzm5kjtbVX0KdhFhdtPudKKT45MQeJgCoTm4EUetqHWIotZxFKYkVLBCqUFxhATRYiqh7LZNRDAGc0ApIIbRAhsNyP4ISXXRqDC3H5mQ2n4gCTOjUIowIaBQJi1HyMNclVnnmBXzTEY3FkPFBzMrPHVEyyj3yzzhhKrBU6h78iPh9p94TKnKGL5vLlXmulVYYtsN0gqSv4XkK7iWViKZ3bO/7HPDWPjCqCdbAfMUca6PA2G4rtGx87HrRgyE5cWm/kTdpFdvtlikoF7P7C/Bq9POyEwZJa4ia2XQgNKT8bBeY9+2PH3ACibSnz59ozwVd+r1dW8XZ56iL86EVRrNZBrftE66R3Gn40zrHxbUNVn4zEiRQWgVkap9hG7IZ2JfibM8qTb1wJI3TJCiOhUEM6ipT5Gj/lpmPJTT3rjnj9dlR6XRT2fXroD9akDeXxV/K03TtPcHam7JyUfGs/SoDfzlZCs1x8vNxchqLVtonal3YbjAquRacyb/g8y3U/74u8V5qbHKmrPMHp5Cn5ZlwfPx4sr5f1Vg+94qtvO3t5dKH1oa2OMcyvTgTcSHZ6+fFx6vFN7CHj3RMX9uivIfa6tLvopAM62uAPfKRPZc+bm04vBlNqM1L2q1uEzC8jWvf5CE+Ute/+A3BFqu2Q==
101AqBTzL4ftGuFa